SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Clinical measures associated with aspiration risk in multiple system atrophy: a cross-sectional study.

Clin Park Relat Disord · 2025-10-17

DOI: 10.1016/j.prdoa.2025.100401PMID: 41210147

Open accessbrief-report; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

IntroductionIdentifying clinical measures associated with aspiration risk is crucial for guiding clinical decisions in patients with multiple system atrophy (MSA). We investigated whether basic clinical measures-including the Barthel index (BI), Unified MSA Rating Scale (UMSARS), and dopamine transporter single-photon emission computed tomography imaging (DaT imaging)-are associated with aspiration risk in patients with MSA.MethodsThis cross-sectional, single-center study analyzed patients with MSA who underwent videofluoroscopic swallowing examinations (VF) and DaT imaging within 12 months of each other. Clinical measures were assessed within 3 months of VF. Patients were categorized into aspiration and non-aspiration groups based on VF findings. Multivariable modified Poisson regression and receiver operating characteristic (ROC) analyses were performed to explore the associations between clinical measures and aspiration, and their discriminative ability.ResultsAmong 105 patients with MSA (58 females; median age: 63 years [range: 43-87 years]), 28 (26.7 %) showed aspiration on VF. The aspiration group showed significantly lower BI and higher UMSARS scores than the non-aspiration group. In multivariable regression analyses, BI was consistently and significantly associated with aspiration across all models. ROC analysis demonstrated moderate discriminative ability both BI (AUC 0.77, 95 %CI 0.66-0.87) and UMSARS (AUC 0.73, 95 %CI 0.63-0.83) for aspiration, with overlapping confidence intervals. The association was particularly notable for the parkinsonian MSA subtype.ConclusionThe BI shows potential as a clinical marker of aspiration risk in MSA, particularly in the parkinsonian subtype, which may help guide the timing of swallowing assessments even in the absence of overt dysphagia symptoms.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.